カテゴリー： QYResearch, 世界

世界の若年性黄斑変性症治療市場 2019年

【英語タイトル】Global Juvenile Macular Degeneration Treatment Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X10164）・商品コード：DATA909X10164
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、若年性黄斑変性症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アバンサカプタドペゴルナトリウム、エコチオパートヨウ化物、エミクススタト塩酸塩、FAB-111、その他に、用途別には、クリニック、病院、在宅ケアにセグメント区分し、若年性黄斑変性症治療の世界市場を分析しました。


・エグゼクティブ・サマリー
・若年性黄斑変性症治療の世界市場概要
・若年性黄斑変性症治療の製造コスト構成分析
・若年性黄斑変性症治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・若年性黄斑変性症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・若年性黄斑変性症治療のセグメント分析（種類別）
（アバンサカプタドペゴルナトリウム、エコチオパートヨウ化物、エミクススタト塩酸塩、FAB-111、その他）
・若年性黄斑変性症治療のセグメント分析（用途別）
（クリニック、病院、在宅ケア）
・若年性黄斑変性症治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Acucela Inc.、Alkeus Pharmaceuticals Inc、Astellas Pharma Inc、Copernicus Therapeutics Inc、Grupo Ferrer Internacional SA、Iris Pharma、Sanofi、）
・若年性黄斑変性症治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Juvenile Macular Degeneration Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Juvenile Macular Degeneration Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Juvenile Macular Degeneration Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Juvenile Macular Degeneration Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Juvenile Macular Degeneration Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Acucela Inc.
Alkeus Pharmaceuticals Inc
Astellas Pharma Inc
Copernicus Therapeutics Inc
Grupo Ferrer Internacional SA
Iris Pharma
Sanofi
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Avacincaptad Pegol Sodium
Echothiophate Iodide
Emixustat Hydrochloride
FAB-111
Others

Segment by Application
Clinic
Hospital
Homecare

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Juvenile Macular Degeneration Treatment
1.1 Definition of Juvenile Macular Degeneration Treatment
1.2 Juvenile Macular Degeneration Treatment Segment by Type
1.2.1 Global Juvenile Macular Degeneration Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Avacincaptad Pegol Sodium
1.2.3 Echothiophate Iodide
1.2.4 Emixustat Hydrochloride
1.2.5 FAB-111
1.2.6 Others
1.3 Juvenile Macular Degeneration Treatment Segment by Applications
1.3.1 Global Juvenile Macular Degeneration Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Global Juvenile Macular Degeneration Treatment Overall Market
1.4.1 Global Juvenile Macular Degeneration Treatment Revenue (2014-2025)
1.4.2 Global Juvenile Macular Degeneration Treatment Production (2014-2025)
1.4.3 North America Juvenile Macular Degeneration Treatment Status and Prospect (2014-2025)
1.4.4 Europe Juvenile Macular Degeneration Treatment Status and Prospect (2014-2025)
1.4.5 China Juvenile Macular Degeneration Treatment Status and Prospect (2014-2025)
1.4.6 Japan Juvenile Macular Degeneration Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Juvenile Macular Degeneration Treatment Status and Prospect (2014-2025)
1.4.8 India Juvenile Macular Degeneration Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Juvenile Macular Degeneration Treatment
2.3 Manufacturing Process Analysis of Juvenile Macular Degeneration Treatment
2.4 Industry Chain Structure of Juvenile Macular Degeneration Treatment

3 Development and Manufacturing Plants Analysis of Juvenile Macular Degeneration Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Juvenile Macular Degeneration Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Juvenile Macular Degeneration Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Juvenile Macular Degeneration Treatment Production and Capacity Analysis
4.2 Juvenile Macular Degeneration Treatment Revenue Analysis
4.3 Juvenile Macular Degeneration Treatment Price Analysis
4.4 Market Concentration Degree

5 Juvenile Macular Degeneration Treatment Regional Market Analysis
5.1 Juvenile Macular Degeneration Treatment Production by Regions
5.1.1 Global Juvenile Macular Degeneration Treatment Production by Regions
5.1.2 Global Juvenile Macular Degeneration Treatment Revenue by Regions
5.2 Juvenile Macular Degeneration Treatment Consumption by Regions
5.3 North America Juvenile Macular Degeneration Treatment Market Analysis
5.3.1 North America Juvenile Macular Degeneration Treatment Production
5.3.2 North America Juvenile Macular Degeneration Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Juvenile Macular Degeneration Treatment Import and Export
5.4 Europe Juvenile Macular Degeneration Treatment Market Analysis
5.4.1 Europe Juvenile Macular Degeneration Treatment Production
5.4.2 Europe Juvenile Macular Degeneration Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Juvenile Macular Degeneration Treatment Import and Export
5.5 China Juvenile Macular Degeneration Treatment Market Analysis
5.5.1 China Juvenile Macular Degeneration Treatment Production
5.5.2 China Juvenile Macular Degeneration Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Juvenile Macular Degeneration Treatment Import and Export
5.6 Japan Juvenile Macular Degeneration Treatment Market Analysis
5.6.1 Japan Juvenile Macular Degeneration Treatment Production
5.6.2 Japan Juvenile Macular Degeneration Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Juvenile Macular Degeneration Treatment Import and Export
5.7 Southeast Asia Juvenile Macular Degeneration Treatment Market Analysis
5.7.1 Southeast Asia Juvenile Macular Degeneration Treatment Production
5.7.2 Southeast Asia Juvenile Macular Degeneration Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Juvenile Macular Degeneration Treatment Import and Export
5.8 India Juvenile Macular Degeneration Treatment Market Analysis
5.8.1 India Juvenile Macular Degeneration Treatment Production
5.8.2 India Juvenile Macular Degeneration Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Juvenile Macular Degeneration Treatment Import and Export

6 Juvenile Macular Degeneration Treatment Segment Market Analysis (by Type)
6.1 Global Juvenile Macular Degeneration Treatment Production by Type
6.2 Global Juvenile Macular Degeneration Treatment Revenue by Type
6.3 Juvenile Macular Degeneration Treatment Price by Type

7 Juvenile Macular Degeneration Treatment Segment Market Analysis (by Application)
7.1 Global Juvenile Macular Degeneration Treatment Consumption by Application
7.2 Global Juvenile Macular Degeneration Treatment Consumption Market Share by Application (2014-2019)

8 Juvenile Macular Degeneration Treatment Major Manufacturers Analysis
8.1 Acucela Inc.
8.1.1 Acucela Inc. Juvenile Macular Degeneration Treatment Production Sites and Area Served
8.1.2 Acucela Inc. Product Introduction, Application and Specification
8.1.3 Acucela Inc. Juvenile Macular Degeneration Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Alkeus Pharmaceuticals Inc
8.2.1 Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Production Sites and Area Served
8.2.2 Alkeus Pharmaceuticals Inc Product Introduction, Application and Specification
8.2.3 Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Astellas Pharma Inc
8.3.1 Astellas Pharma Inc Juvenile Macular Degeneration Treatment Production Sites and Area Served
8.3.2 Astellas Pharma Inc Product Introduction, Application and Specification
8.3.3 Astellas Pharma Inc Juvenile Macular Degeneration Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Copernicus Therapeutics Inc
8.4.1 Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Production Sites and Area Served
8.4.2 Copernicus Therapeutics Inc Product Introduction, Application and Specification
8.4.3 Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Grupo Ferrer Internacional SA
8.5.1 Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Production Sites and Area Served
8.5.2 Grupo Ferrer Internacional SA Product Introduction, Application and Specification
8.5.3 Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Iris Pharma
8.6.1 Iris Pharma Juvenile Macular Degeneration Treatment Production Sites and Area Served
8.6.2 Iris Pharma Product Introduction, Application and Specification
8.6.3 Iris Pharma Juvenile Macular Degeneration Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Sanofi
8.7.1 Sanofi Juvenile Macular Degeneration Treatment Production Sites and Area Served
8.7.2 Sanofi Product Introduction, Application and Specification
8.7.3 Sanofi Juvenile Macular Degeneration Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served

9 Development Trend of Analysis of Juvenile Macular Degeneration Treatment Market
9.1 Global Juvenile Macular Degeneration Treatment Market Trend Analysis
9.1.1 Global Juvenile Macular Degeneration Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Juvenile Macular Degeneration Treatment Regional Market Trend
9.2.1 North America Juvenile Macular Degeneration Treatment Forecast 2019-2025
9.2.2 Europe Juvenile Macular Degeneration Treatment Forecast 2019-2025
9.2.3 China Juvenile Macular Degeneration Treatment Forecast 2019-2025
9.2.4 Japan Juvenile Macular Degeneration Treatment Forecast 2019-2025
9.2.5 Southeast Asia Juvenile Macular Degeneration Treatment Forecast 2019-2025
9.2.6 India Juvenile Macular Degeneration Treatment Forecast 2019-2025
9.3 Juvenile Macular Degeneration Treatment Market Trend (Product Type)
9.4 Juvenile Macular Degeneration Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Juvenile Macular Degeneration Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Juvenile Macular Degeneration Treatment
Table Global Juvenile Macular Degeneration Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Juvenile Macular Degeneration Treatment Production Market Share by Types in 2018
Figure Avacincaptad Pegol Sodium Product Picture
Figure Echothiophate Iodide Product Picture
Figure Emixustat Hydrochloride Product Picture
Figure FAB-111 Product Picture
Figure Others Product Picture
Table Global Juvenile Macular Degeneration Treatment Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Juvenile Macular Degeneration Treatment Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Homecare
Figure Global Juvenile Macular Degeneration Treatment Revenue (Million USD) (2014-2025)
Figure Global Juvenile Macular Degeneration Treatment Production (K Pcs) (2014-2025)
Figure North America Juvenile Macular Degeneration Treatment Market Size (Million USD) (2014-2025)
Figure Europe Juvenile Macular Degeneration Treatment Market Size (Million USD) (2014-2025)
Figure China Juvenile Macular Degeneration Treatment Market Size (Million USD) (2014-2025)
Figure Japan Juvenile Macular Degeneration Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Juvenile Macular Degeneration Treatment Market Size (Million USD) (2014-2025)
Figure India Juvenile Macular Degeneration Treatment Market Size (Million USD) (2014-2025)
Table Juvenile Macular Degeneration Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Juvenile Macular Degeneration Treatment in 2018
Figure Manufacturing Process Analysis of Juvenile Macular Degeneration Treatment
Figure Industry Chain Structure of Juvenile Macular Degeneration Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Juvenile Macular Degeneration Treatment Manufacturing Plants Distribution
Table Juvenile Macular Degeneration Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Juvenile Macular Degeneration Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Juvenile Macular Degeneration Treatment Production (K Pcs) of Major Manufacturers (2014-2019)
Table Juvenile Macular Degeneration Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Juvenile Macular Degeneration Treatment Production Share by Manufacturers in 2018
Table Juvenile Macular Degeneration Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Juvenile Macular Degeneration Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Juvenile Macular Degeneration Treatment Revenue Share by Manufacturers in 2018
Table Juvenile Macular Degeneration Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Juvenile Macular Degeneration Treatment Production by Regions 2014-2019 (K Pcs)
Table Global Juvenile Macular Degeneration Treatment Production Market Share by Regions 2014-2019
Figure Global Juvenile Macular Degeneration Treatment Production Market Share by Regions in 2018
Table Global Juvenile Macular Degeneration Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Juvenile Macular Degeneration Treatment Revenue Market Share by Regions 2014-2019
Figure Global Juvenile Macular Degeneration Treatment Revenue Market Share by Regions in 2018
Table Global Juvenile Macular Degeneration Treatment Consumption by Regions 2014-2019 (K Pcs)
Table Global Juvenile Macular Degeneration Treatment Consumption Market Share by Regions 2014-2019
Figure North America Juvenile Macular Degeneration Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure North America Juvenile Macular Degeneration Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Juvenile Macular Degeneration Treatment Production, Consumption Import and Export (K Pcs)
Figure Europe Juvenile Macular Degeneration Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Juvenile Macular Degeneration Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Juvenile Macular Degeneration Treatment Production, Consumption Import and Export (K Pcs)
Figure China Juvenile Macular Degeneration Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure China Juvenile Macular Degeneration Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Juvenile Macular Degeneration Treatment Production, Consumption Import and Export (K Pcs)
Figure Japan Juvenile Macular Degeneration Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Juvenile Macular Degeneration Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Juvenile Macular Degeneration Treatment Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Juvenile Macular Degeneration Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Juvenile Macular Degeneration Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Juvenile Macular Degeneration Treatment Production, Consumption Import and Export (K Pcs)
Figure India Juvenile Macular Degeneration Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure India Juvenile Macular Degeneration Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Juvenile Macular Degeneration Treatment Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Juvenile Macular Degeneration Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Juvenile Macular Degeneration Treatment Market Share by Application (2014-2019)
Table Acucela Inc. Juvenile Macular Degeneration Treatment Production Sites and Area Served
Table Acucela Inc. Juvenile Macular Degeneration Treatment Product Introduction, Application and Specification
Table Acucela Inc. Juvenile Macular Degeneration Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Acucela Inc. Juvenile Macular Degeneration Treatment Production Growth Rate (2014-2019)
Table Acucela Inc. Juvenile Macular Degeneration Treatment Production Market Share (2014-2019)
Figure Acucela Inc. Juvenile Macular Degeneration Treatment Revenue Market Share (2014-2019)
Table Acucela Inc. Juvenile Macular Degeneration Treatment Main Business and Markets Served
Table Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Production Sites and Area Served
Table Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Product Introduction, Application and Specification
Table Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Production Growth Rate (2014-2019)
Table Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Production Market Share (2014-2019)
Figure Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Revenue Market Share (2014-2019)
Table Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Main Business and Markets Served
Table Astellas Pharma Inc Juvenile Macular Degeneration Treatment Production Sites and Area Served
Table Astellas Pharma Inc Juvenile Macular Degeneration Treatment Product Introduction, Application and Specification
Table Astellas Pharma Inc Juvenile Macular Degeneration Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Astellas Pharma Inc Juvenile Macular Degeneration Treatment Production Growth Rate (2014-2019)
Table Astellas Pharma Inc Juvenile Macular Degeneration Treatment Production Market Share (2014-2019)
Figure Astellas Pharma Inc Juvenile Macular Degeneration Treatment Revenue Market Share (2014-2019)
Table Astellas Pharma Inc Juvenile Macular Degeneration Treatment Main Business and Markets Served
Table Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Production Sites and Area Served
Table Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Product Introduction, Application and Specification
Table Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Production Growth Rate (2014-2019)
Table Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Production Market Share (2014-2019)
Figure Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Revenue Market Share (2014-2019)
Table Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Main Business and Markets Served
Table Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Production Sites and Area Served
Table Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Product Introduction, Application and Specification
Table Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Production Growth Rate (2014-2019)
Table Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Production Market Share (2014-2019)
Figure Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Revenue Market Share (2014-2019)
Table Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Main Business and Markets Served
Table Iris Pharma Juvenile Macular Degeneration Treatment Production Sites and Area Served
Table Iris Pharma Juvenile Macular Degeneration Treatment Product Introduction, Application and Specification
Table Iris Pharma Juvenile Macular Degeneration Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Iris Pharma Juvenile Macular Degeneration Treatment Production Growth Rate (2014-2019)
Table Iris Pharma Juvenile Macular Degeneration Treatment Production Market Share (2014-2019)
Figure Iris Pharma Juvenile Macular Degeneration Treatment Revenue Market Share (2014-2019)
Table Iris Pharma Juvenile Macular Degeneration Treatment Main Business and Markets Served
Table Sanofi Juvenile Macular Degeneration Treatment Production Sites and Area Served
Table Sanofi Juvenile Macular Degeneration Treatment Product Introduction, Application and Specification
Table Sanofi Juvenile Macular Degeneration Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sanofi Juvenile Macular Degeneration Treatment Production Growth Rate (2014-2019)
Table Sanofi Juvenile Macular Degeneration Treatment Production Market Share (2014-2019)
Figure Sanofi Juvenile Macular Degeneration Treatment Revenue Market Share (2014-2019)
Table Sanofi Juvenile Macular Degeneration Treatment Main Business and Markets Served
Figure Global Juvenile Macular Degeneration Treatment Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Juvenile Macular Degeneration Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Juvenile Macular Degeneration Treatment Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Juvenile Macular Degeneration Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Juvenile Macular Degeneration Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Juvenile Macular Degeneration Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Juvenile Macular Degeneration Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Juvenile Macular Degeneration Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Juvenile Macular Degeneration Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Juvenile Macular Degeneration Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Juvenile Macular Degeneration Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Juvenile Macular Degeneration Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Juvenile Macular Degeneration Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Juvenile Macular Degeneration Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Juvenile Macular Degeneration Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Juvenile Macular Degeneration Treatment by Type (2019-2025)
Table Global Consumption (K Pcs) of Juvenile Macular Degeneration Treatment by Application (2019-2025)
Table Juvenile Macular Degeneration Treatment Distributors List
Table Juvenile Macular Degeneration Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Acucela Inc.、Alkeus Pharmaceuticals Inc、Astellas Pharma Inc、Copernicus Therapeutics Inc、Grupo Ferrer Internacional SA、Iris Pharma、Sanofi、

★調査レポート[世界の若年性黄斑変性症治療市場 2019年] (コード：DATA909X10164)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の若年性黄斑変性症治療市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 加齢黄斑変性症(AMD)治療の世界市場：規模・現状・予測2019-2025
    DATA909X18135 / QYResearch / 2019年11月25日 / ※当調査レポートでは、加齢黄斑変性症(AMD)治療の世界市場について調査・分析し、加齢黄斑変性症(AMD)治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ウェットAMD、ドライAMD）、用途別（病院、クリニック、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の加齢黄斑変性症(AMD)治療市場動向 ・主要企業別マーケットシェア ・加齢黄斑変性症(AMD)治療の種類別市場規模2014-2019 （ウェットAMD、ドライAMD） ・加齢黄斑変性症(AMD)治療の用途別市場規模2014-2019 （病院、クリニック、研究所、その他） ・加齢黄斑変性症(AMD)治療の北米市場：主要企業・種類別/用途別市場規模 ・加齢黄斑変性症(AMD)治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.Age-related macular degeneration is a progressive condition, and it is common among the geriatric population. The growing geriatric population is contributing to the rising incidence of age-related macular degeneration globally. As a result, there is a high demand for therapeutics to treat the condition. Pharmaceutical companies are leveraging this opportunity and are focusing on releasing drugs to treat age-related macular degeneration. In 2018, the global Age-Related Macular Degeneration (AMD) Therapeutics market size was xx million US$ and it is...
  • 世界の加齢黄斑変性症(AMD)市場 2019年
    DATA909X03077 / QYResearch / 2019年11月15日 / ※本調査レポートは、加齢黄斑変性症(AMD)の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ウェットAMD、ドライAMDに、用途別には、ドラッグストア、病院、その他にセグメント区分し、加齢黄斑変性症(AMD)の世界市場を分析しました。 ・エグゼクティブ・サマリー ・加齢黄斑変性症(AMD)の世界市場概要 ・加齢黄斑変性症(AMD)の製造コスト構成分析 ・加齢黄斑変性症(AMD)の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・加齢黄斑変性症(AMD)の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・加齢黄斑変性症(AMD)のセグメント分析（種類別） （ウェットAMD、ドライAMD）...The global Age-related Macular Degeneration market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Age-related Macular Degeneration volume and value at global level, regional level and company level. From a global perspective, this report represents overall Age-related Macular Degeneration market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Age-related Macular Degeneration in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の全身性特発性若年性関節炎の治療市場 2019年
    DATA909X16229 / QYResearch / 2019年11月20日 / ※本調査レポートは、全身性特発性若年性関節炎の治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アダリムマブバイオシミラー、カナキヌマブ、ゴリムマブ、トシリズマブバイオシミラー、その他に、用途別には、クリニック、病院、その他にセグメント区分し、全身性特発性若年性関節炎の治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・全身性特発性若年性関節炎の治療の世界市場概要 ・全身性特発性若年性関節炎の治療の製造コスト構成分析 ・全身性特発性若年性関節炎の治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・全身性特発性若年性関節炎の治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・全身性特発性若年性関節炎の治療のセグメント分析（種類別） （アダリムマブバイオシミラー、カナキヌマブ、ゴリムマブ、トシリズマブバイオシミラー、その他）...The global Systemic Idiopathic Juvenile Arthritis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Systemic Idiopathic Juvenile Arthritis Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Systemic Idiopathic Juvenile Arthritis Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Systemic Idiopathic Juvenile Arthritis Treatment in North America, Europe, China, Japan, Southeast Asia and...

    • ◆H&Iグローバルリサーチのお客様（例）◆